approved EB-2 (NIW)

Gastroenterology Fellow

Gastroenterology · United Arab Emirates · 2025-07-25

Processing Time
128 days
Decision Date
2025-07-25
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate patient-centered outcomes to identify barriers to adherence in therapies for chronic gastrointestinal conditions. This work involves assessing therapeutic efficacy and patient response variability in inflammatory bowel disease and motility disorders to develop predictive clinical models for personalized treatment strategies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The work addresses urgent clinical challenges in treatment adherence and aligns with national healthcare cost-reduction goals.

2 Well Positioned to Advance the Endeavor Met

The petitioner's fellowship at a leading medical center and extensive publication/review record demonstrate readiness to lead future advances.

3 Balance of Factors Met

The national interest in improving patient care and reducing healthcare burdens justifies the waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 5 peer-reviewed journal articles, 15 conference abstracts, and 38 citations. Additionally, the petitioner completed 13 invited manuscript reviews for leading medical journals and demonstrated alignment with national public-health agency priorities, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Government Alignment
Reference Letters Independent

Similar Cases

Doctor

Healthcare · India

WeGreened EB-2 (NIW) approved
South Dakota 51 days 2025-02-27
The petitioner proposes to continue clinical research in gastroenterology and hepatology, focusing on outcome studies, screening programs for chronic cholecystitis, and cost analyses to reduce the financial burden of gastrointestinal diseases on the U.S. healthcare system.

Others

Healthcare · India

WeGreened EB-2 (NIW) approved
Minnesota 97 days 2025-01-24
The petitioner proposes to advance research focused on developing cutting-edge molecular diagnostic tools, pioneering innovative treatment strategies, and implementing comprehensive patient care models. Specifically, the work aims to study risk factors and transform the early diagnosis and management of gastrointestinal and liver diseases, including cancer.

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
213 days 2025-07-08
The petitioner proposes to use multi-omics tools to investigate disease mechanisms, specifically focusing on inflammatory bowel disease (IBD) and gastrointestinal cancers. This work aims to develop healthcare solutions for chronic conditions and improve public health outcomes through precision medicine.
WeGreened EB-2 (NIW) approved
45 days 2025-05-31
The petitioner proposes to continue advancing the treatment and management of complex gastrointestinal and liver diseases, including cirrhosis, hepatic encephalopathy, and colorectal cancer, through evidence-based clinical research.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 128 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist